---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-080719"
form_type: "8-K"
ticker: "TXMD"
cik: "0000025743"
company_name: "TherapeuticsMD, Inc."
filed_at: "2024-09-20T23:59:59+00:00"
generated_at: "2026-05-31T03:21:22.048226+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# TherapeuticsMD sets 2024 annual meeting for Dec 5; proxy deadlines Sep 30

## Summary
- 2024 Annual Meeting scheduled for December 5, 2024; record date October 17, 2024.
- Stockholder proposals for inclusion in proxy materials (Rule 14a-8) must be received by September 30, 2024.
- Director nominations and other proposals must also be submitted by close of business September 30, 2024.
- Meeting is more than 30 days after anniversary of 2023 meeting, triggering revised deadlines.

## SEC filing metadata
- accession: 0001213900-24-080719
- form_type: 8-K
- ticker: TXMD
- cik: 0000025743
- company_name: TherapeuticsMD, Inc.
- filed_at: 2024-09-20T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.08
- EDGAR index: https://www.sec.gov/Archives/edgar/data/25743/000121390024080719/0001213900-24-080719-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/25743/000121390024080719/ea0215273-8k_therap.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-080719
- JSON: https://secwatch.observer/filing/0001213900-24-080719.json
- Plain text: https://secwatch.observer/filing/0001213900-24-080719.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.